Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

7,212

Participants

Timeline

Start Date

December 1, 2014

Primary Completion Date

July 31, 2019

Study Completion Date

December 28, 2019

Conditions
Thrombophilia Associated With PregnancyPerioperative/Postoperative ComplicationsVenous ThrombosisPulmonary EmbolismOther Specified Risk Factors in PregnancyDeep Vein Thrombosis
Interventions
DRUG

Enoxaparin

Patients who score higher or equal to 3, receive a prophylactic dose of enoxaparin. The first dose of enoxaparin is administered 8 hours after vaginal or abdominal delivery. Subsequent doses are administered daily for up to 15 days. The dose depends on patient weight.

OTHER

No intervention

Hospitalized patients that score less than three are not prescribed enoxaparin.

Trial Locations (1)

05403000

University of Sao Paulo General Hospital, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT02600260 - Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial | Biotech Hunter | Biotech Hunter